Zhiguo Tan
Jiefang West Road, 41000
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Resveratrol Attenuates Gemcitabine Resistance in Hepatocellular Carcinoma Cells by Inhibiting Thymidylate Synthase.
Journal: Frontiers in bioscience (Landmark edition)
Published: March 31, 2026
Hepatocellular carcinoma-cholangiocarcinoma collision tumor with excellent therapeutic response: a case report and literature review.
Journal: Discover oncology
Published: February 04, 2026
Prognostic outcomes of surgery vs. non-surgery in initially unresectable HCC with successful conversion via ICI + TKI therapy.
Journal: BMC gastroenterology
Published: December 10, 2025
Surgery vs. non-surgery for advanced cholangiocarcinoma post-conversion therapy with PD-1/PD-L1 inhibitors plus TKIs.
Journal: Frontiers in immunology
Published: November 24, 2025
Integration of Meta-Analysis and Network Pharmacology to Investigate the Pharmacological Mechanisms of Quercetin on Hepatocellular Carcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: September 03, 2025
HBV-driven expansion of CXCR6+-exhausted T cells and CXCL16+ macrophage interaction: Implications for immunotherapy in HCC.
Journal: Innovation (Cambridge (Mass.))
Published: August 31, 2025
CGR11 promotes hepatocellular carcinoma progression by regulating autophagy through the PI3K/AKT pathway.
Journal: Frontiers in cell and developmental biology
Published: August 25, 2025
Mitochondrial function in intestinal ischemia-reperfusion injury: mechanisms and therapeutic perspectives.
Journal: Molecular biology reports
Published: May 21, 2025
Network pharmacology to explore the novel anti-inflammatory mechanism of naringenin in intestinal ischemia/reperfusion injury.
Journal: Frontiers in immunology
Published: May 05, 2025
The optimal number of examined lymph nodes for cancer specific death of intrahepatic cholangiocarcinoma: a population-based study.
Journal: Discover oncology
Published: December 23, 2024
Identification of a JAK-STAT-miR155HG positive feedback loop in regulating natural killer (NK) cells proliferation and effector functions.
Journal: Acta pharmaceutica Sinica. B
Published: October 15, 2024
Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway.
Journal: Discover oncology
Published: October 01, 2024
Last Updated: 09/26/2026